Oxymatrine Attenuates Ulcerative Colitis through Inhibiting Pyroptosis Mediated by the NLRP3 Inflammasome

Jing Sun,Shuai Wang,Zhengtian Zhao,Jiaqi Lu,Yiming Zhang,Wen An,Wei Li,Li Yang,Xiaowei Tong

DOI: https://doi.org/10.3390/molecules29122897

IF: 4.6

2024-06-19

Molecules

Abstract:Ulcerative colitis (UC) is difficult to cure and easy to relapse, leading to poor quality of life for patients. Oxymatrine (OMT) is one of the main alkaloids of Sophora flavescens Aiton, which has many effects, such as anti-inflammation, anti-oxidative stress, and immunosuppression. This study aimed to investigate whether OMT could attenuate ulcerative colitis by inhibiting the NOD-like receptor family pyrin domain containing three (NLRP3) inflammasome-mediated pyroptosis. In this study, the UC rat models were established by 2,4,6-Trinitrobenzenesulfonic acid (TNBS) in vivo, while RAW264.7 cells and peritoneal macrophages were stimulated with Lipopolysaccharides/Adenosine Triphosphate (LPS/ATP) in vitro to simulate pyroptosis models, and Western blotting (WB) and other detection techniques were applied to analyze proteins involved in the NLRP3 inflammasome pathway. Our results showed that OMT alleviated colitis ulcers and pathological damage in the TNBS-induced UC rats and exhibited an inhibitory effect on pyroptosis at the early stage of UC. In the model group, the pyroptosis reached the peak at 24 h after modeling with the contents of active-cysteine-aspartic proteases-1 (caspase-1), Gasdermin D (GSDMD)-N, and cleaved-interleukin-1 beta (IL-1β) to the highest expression level. Meanwhile, we found that OMT (80 mg kg−1) remarkably decreased the expression levels of NLRP3, active-caspase-1, and cleaved-IL-1β at 24 h in the lesion tissue from UC rats. Further experiments on cells demonstrated that OMT at concentrations of 100 and 250 μM significantly inhibited cell death caused by NLRP3 inflammasome activation (p < 0.05), downregulated caspase-1, GSDMD, and decreased the levels of active-caspase-1, GSDMD-N, cleaved-IL-1β in RAW326.7 cells, and peritoneal macrophages. In summary, these results indicated that OMT could attenuate ulcerative colitis through inhibiting pyroptosis mediated by the NLRP3 inflammasome. The inhibition of the NLRP3 inflammasome may be a potential strategy for UC.

chemistry, multidisciplinary,biochemistry & molecular biology

What problem does this paper attempt to address?

This paper aims to investigate whether oxymatrine (OMT) can alleviate ulcerative colitis (UC) by inhibiting NLRP3 inflammasome-mediated pyroptosis. Specifically, the paper explores the effects of OMT on the expression of proteins related to the NLRP3 inflammasome signaling pathway through in vivo (rat model) and in vitro (RAW264.7 cells and peritoneal macrophages) experiments, and verifies the inhibitory effect of OMT on pyroptosis in the early stages of UC. The study shows that OMT can significantly alleviate TNBS-induced UC symptoms in rats and reduce the expression levels of NLRP3, activated caspase-1, and cleaved IL-1β in the lesion tissues. Additionally, in cell experiments, OMT also exhibits significant anti-pyroptosis effects, capable of inhibiting NLRP3 inflammasome activation and pyroptosis in macrophages induced by LPS/ATP stimulation. These results suggest that OMT may be a potential drug for the treatment of UC, with its mechanism mainly related to the inhibition of NLRP3 inflammasome-mediated pyroptosis.

Oxymatrine Attenuates Ulcerative Colitis through Inhibiting Pyroptosis Mediated by the NLRP3 Inflammasome

PDE9 Inhibitor PF-04447943 Attenuates DSS-Induced Colitis by Suppressing Oxidative Stress, Inflammation, and Regulating T-Cell Polarization

Oxymatrine alleviates NSAID-associated small bowel mucosal injury by regulating MIP-1/CCR1 signalling and gut microbiota

Oxymatrine loaded nitric oxide-releasing liposomes for the treatment of ulcerative colitis

Oxymatrine blocks the NLRP3 inflammasome pathway, partly downregulating the inflammatory responses of M1 macrophages differentiated from THP-1 monocytes

Oxymatrine Improves TNBS-induced Colitis in Rats by Inhibiting the Expression of NF-κB P65

Beneficial effects of oxymatrine from Sophora flavescens on alleviating Ulcerative colitis by improving inflammation and ferroptosis

Matrine: A Promising Treatment for Ulcerative Colitis by Targeting the HMGB1/NLRP3/Caspase-1 Pathway

Oxymatrine inhibits neuroinflammation by Regulating M1/M2 polarization in N9 microglia through the TLR4/NF-κB pathway

Oxymatrine attenuates sepsis‐induced inflammation and organ injury via inhibition of HMGB1/RAGE/NF‐κB signaling pathway

Oxymatrine suppresses colorectal cancer progression by inhibiting NLRP3 inflammasome activation through mitophagy induction in vitro and in vivo

Oxymatrine Exerts Protective Effects on Osteoarthritis Via Modulating Chondrocyte Homoeostasis and Suppressing Osteoclastogenesis

Oxymatrine ameliorates agomelatine-induced hepatocyte injury through promoting proteasome-mediated CHOP degradation

Anti-Inflammatory Effects of Oxymatrine Through Inhibition of Nuclear Factor-Kappa B and Mitogen-Activated Protein Kinase Activation in Lipopolysaccharide-Induced Bv2 Microglia Cells

Matrine protects colon mucosal epithelial cells against inflammation and apoptosis via the Janus kinase 2 /signal transducer and activator of transcription 3 pathway

Honokiol Alleviates Ulcerative Colitis by Targeting PPAR-γ–TLR4–NF-κB Signaling and Suppressing Gasdermin-D-mediated Pyroptosis in Vivo and in Vitro

Oxymatrine Causes Hepatotoxicity by Promoting the Phosphorylation of JNK and Induction of Endoplasmic Reticulum Stress Mediated by ROS in LO2 Cells

Oxymatrine protects articular chondrocytes from IL-1β-induced damage through autophagy activation via AKT/mTOR signaling pathway inhibition

A proteomics-based study of the mechanism of oxymatrine to ameliorate hepatic fibrosis in mice

The investigation on sialic acid-modified pectin nanoparticles loaded with oxymatrine for orally targeting and inhibiting the of ulcerative colitis

Matrine Ameliorates DSS-Induced Colitis by Suppressing Inflammation, Modulating Oxidative Stress and Remodeling the Gut Microbiota